索尔克新闻


Tickets now on sale for 29th annual Symphony at Salk, featuring the San Diego Symphony and Kristin Chenoweth on August 16

LA JOLLA—Tickets are now available for the 29th annual 索尔克音乐会, an evening where music, science, and philanthropy converge for a spectacular celebration. Set against the backdrop of the Salk Institute’s iconic architecture, this exclusive event will take place on Saturday, August 16, 2025, and feature the San Diego Symphony performing with Emmy and Tony Award-winning performer Kristin Chenoweth.

Symphony at Salk
索尔克音乐会
点击此处 用于高分辨率图像。.
版权:萨克研究所

Guests will experience the elegance of the evening with a champagne reception, gourmet dinner, and immersive musical performances, all while contributing to the Salk Institute’s mission to better understand and address some of the world’s most pressing challenges.

This year’s event will feature a special focus on Salk’s Year of Alzheimer’s Disease Research. Guests will learn how Salk scientists are rewriting the narrative on Alzheimer’s, a devastating disease that continues to take a heartbreaking toll on families despite decades of investment. Cross-disciplinary Salk teams are now exploring a largely overlooked driver of the disease—chronic inflammation—rather than focusing solely on traditional hallmarks. By investigating this underlying factor across all brain cell types, not just neurons, they are uncovering new avenues for early detection and treatment.

“Symphony at Salk is more than just a concert—it is an opportunity to celebrate the profound intersection of art and science,” says Amy Jacobs, member of Salk’s Board of Trustees and chair of the Symphony at Salk committee. “As Salk scientists continue to push the boundaries of knowledge in Alzheimer’s and other critical areas of research, events like this help bring those breakthroughs to life.”

Tickets, sponsorships, and advertising opportunities can be purchased at symphony.salk.edu.

更多信息

宣传办公室
电话:(858) 453-4100
press@salk.edu

萨尔克生物学研究所

萨尔克研究所是一个独立的非营利性研究机构,由首个安全有效的脊髓灰质炎疫苗的研发者乔纳斯·索尔克于1960年创立。该研究所的使命是推动以合作、敢于冒险为特点的基础性研究,以应对癌症、阿尔茨海默病和农业脆弱性等社会最紧迫的挑战。这项基础科学支撑着所有的转化研究,产生有助于全球新药和创新的见解。.